Latest Production News

NRW Holdings’ subsidiary Primero Group has landed a $157 million contract from Rio Tinto to deliver critical infrastructure at Hope Downs in Western Australia, extending their longstanding partnership.

Aspermont Limited reports steady subscription growth with $11.2 million in annual recurring revenue despite a dip in total revenue, while gearing up for new data product launches and an IPO.

Tennant Minerals has secured $550,000 through a share placement to fund exploration and development at its Barkly copper-gold project, including the promising Bluebird discovery.

The Arkansas Oil & Gas Commission has approved a 2.5% lithium royalty for brine projects, providing Pantera Lithium with regulatory clarity and a competitive fiscal framework that enhances its Smackover Project’s commercial prospects.

Baumart Holdings has completed a modest capital raise through a rights issue, securing $182,303 before costs, with plans to issue additional shortfall shares to bolster its funding position.

Meeka Metals is on track to commission its upgraded processing plant at the Murchison Gold Project by June 2025, aiming for first gold production shortly thereafter. The company has also expanded its workforce accommodations and advanced underground mine preparations.

Lunnon Metals has revealed promising results from sterilisation drilling near its Lady Herial gold deposit, uncovering a new stacked gold structure that could expand resource potential.

West Coast Silver has initiated a 1,500-metre diamond drilling campaign at its historically rich Elizabeth Hill Silver Project in Western Australia, aiming to unlock new high-grade mineralisation using modern exploration techniques.

Pacific Edge Limited has launched a NZ$20 million capital raise to bolster its cash reserves amid the loss of Medicare coverage for its bladder cancer diagnostic tests, aiming to accelerate US market adoption and support new product development.

Pacific Edge Limited reported a resilient FY25 performance despite losing Medicare coverage for its Cxbladder tests in the US, announcing a $20 million equity raise to support commercialization and growth.

Wellnex Limited has withdrawn its recent announcement referencing a SP Angel research report containing forward-looking financial information, clarifying it does not endorse the projections.

EVE Health Group has successfully passed all shareholder resolutions at its recent General Meeting, paving the way for its acquisition of Nextract Pty Ltd and announcing significant leadership changes.